nach oben

Journal of Cancer Research and Clinical Oncology

Erschienen in:

01.11.2012 | Original Paper

NDRG1/Cap43 overexpression in tumor tissues and serum from lung cancer patients

verfasst von: D. Wang, X. Tian, Y. Jiang

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 11/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The N-myc downstream regulated gene 1 (NDRG1)/Cap43 is overexpressed in multiple cancer types, including lung cancer. In this study, we investigated the expression of NDRG1/Cap43 in lung cancer tissues and in serum from 90 lung cancer patients and 60 healthy controls.

Materials and methods

Ninety patients with pathologically confirmed primary lung cancer who underwent surgical resections were recruited for the study. From resected sections, we dissected lung tumor tissues and adjacent noncancerous tissues that were used as controls and collected patient sera for NDRG1/Cap43 expression levels. Immunohistochemical staining was applied to detect NDRG1/Cap43-positive tumor cells, and real-time quantitative-PCR (RT-PCR) was used to determine mRNA transcript levels of NDRG1/Cap43 in lung cancer tissues. Serum levels of NDRG1/Cap43 were measured by Enzyme-linked immunosorbent assays (ELISA). Data comparison between two groups was performed by independent two sample test, and comparison between more than two groups was applied by the analysis of variance (ANOVA) test.

Results

Compared with adjacent normal tissues, lung cancer tissues had significantly increased expression of NDRG1/Cap43 (P < 0.05). Lung adenocarcinomas also had significantly higher NDRG1/Cap43 levels than lung squamous carcinomas (P < 0.01). RT-PCR analysis showed significantly higher levels of NDRG1/Cap43 mRNA transcripts in lung cancer tissues compared with matched adjacent noncancerous tissues (P < 0.05). mRNA expression of NDRG1/Cap43 was associated with the histological pattern of lung cancer. ELISA analysis for serum NDRG1/Cap43 levels revealed significantly higher levels in lung cancer patients (358.56 ± 233.82 ng/mL) compared with healthy controls (28.83 ± 10.51 ng/mL, P < 0.001).

Conclusions

NDRG1/Cap43 overexpression may be of predictive value in determining the prognosis of lung cancer patients.

Bandyopadhyay S, Pai SK, Gross SC, Hirota S, Hosobe S, Miura K, Saito K, Commes T, Hayashi S, Watabe M, Watabe K (2003) The Drg-1 gene suppresses tumor metastasis in prostate cancer. Cancer Res 63(8):1731–1736PubMed

Bandyopadhyay S, Pai SK, Hirota S, Hosobe S, Takano Y, Saito K, Piquemal D, Commes T, Watabe M, Gross SC, Wang Y, Ran S, Watabe K (2004) Role of the putative tumor metastasis suppressor gene Drg-1 in breast cancer progression. Oncogene 23(33):5675–5681PubMedCrossRef

Brundage MD, Davies D, Mackillop WJ (2002) Prognostic factors in non-small cell lung cancer: a decade of progress. Chest 122(3):1037–1057PubMedCrossRef

Cangul H (2004) Hypoxia upregulates the expression of the NDRG1 gene leading to its overexpression in various human cancers. BMC Genet 5:27PubMedCrossRef

Cangul H, Salnikow K, Yee H, Zagzag D, Commes T, Costa M (2002) Enhanced expression of a novel protein in human cancer cells: a potential aid to cancer diagnosis. Cell Biol Toxicol 18(2):87–96PubMedCrossRef

Chen J, Li S, Yang Z, Lu G, Hu H (2008) Correlation between NDRG1 and PTEN expression in endometrial carcinoma. Cancer Sci 99(4):706–710PubMedCrossRef

Chua MS, Sun H, Cheung ST, Mason V, Higgins J, Ross DT, Fan ST, So S (2007) Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinoma. Mod Pathol 20(1):76–83PubMedCrossRef

Fan C, Yu J, Liu Y, Xu H, Wang E (2010) Increased NDRG1 expression is associated with advanced T stages and poor vascularization in non-small cell lung cancer. Pathol Oncol Res

Fotovati A, Fujii T, Yamaguchi M, Kage M, Shirouzu K, Oie S, Basaki Y, Ono M, Yamana H, Kuwano M (2006) 17Beta-estradiol induces down-regulation of Cap43/NDRG1/Drg-1, a putative differentiation-related and metastasis suppressor gene, in human breast cancer cells. Clin Cancer Res 12(10):3010–3018PubMedCrossRef

Gail MH, Muenz L, McIntire KR, Radovich B, Braunstein G, Brown PR, Deftos L, Dnistrian A, Dunsmore M, Elashoff R, Geller N, Go VLW, Hirji K, Klauber MRD, Petroni G, Schwartz M, Wolfsen AR (1988) Multiple markers for lung cancer diagnosis: validation of models for localized lung cancer. J Natl Cancer Inst 80(2):97–101PubMedCrossRef

Greenberg AK, Lee MS (2010) Biomarkers for lung cancer: clinical uses. Curr Opin Pulm Med 13(4):249–255CrossRef

Guan RJ, Ford HL, Fu Y, Li Y, Shaw LM, Pardee AB (2000) Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer. Cancer Res 60(3):749–755PubMed

Jemal A, Bray F, Melissa M, Ferlay J, Ward E, Forman D (2009) Cancer statistics, 2009. CA Cancer J Clin 59(4):225–249PubMedCrossRef

Jemal A, Bray F et al (2011) Global cancer statistics. CA Cancer J Clin 61(2):69–90PubMedCrossRef

Jiang K, Shen Z, Ye Y, Yang X, Wang S (2010) A novel molecular marker for early detection and evaluating prognosis of gastric cancer: N-myc downstream regulated gene-1 (NDRG1). Scand J Gastroenterol 45(7–8):898–908PubMedCrossRef

Jung EU, Yoon JH, Lee YJ, Lee JH, Kim BH, Yu SJ, Myung SJ, Kim YJ, Lee HS (2010) Hypoxia and retinoic acid-inducible NDRG1 expression is responsible for doxorubicin and retinoic acid resistance in hepatocellular carcinoma cells. Cancer Lett 298(1):9–15PubMedCrossRef

Kalaydjieva L, Hallmayer J, Chandler D, Savov A, Nikolova A, Angelicheva D, King RH, Ishpekova B, Honeyman K, Calafell F, Shmarov A, Petrova J, Turnev I, Hristova A, Moskov M, Stancheva S, Petkova I, Bittles AH, Georgieva V, Middleton L, Thomas PK (1996) Gene mapping in Gypsies identifies a novel demyelinating neuropathy on chromosome 8q24. Nat Genet 14(2):214–217PubMedCrossRef

Lachat P, Shaw P, Gebhard S, van Belzen N, Chaubert P, Bosman FT (2002) Expression of NDRG1, a differentiation-related gene, in human tissues. Histochem Cell Biol 118(5):399–408PubMedCrossRef

Masuda K, Ono M, Okamoto M, Morikawa W, Otsubo M, Migita T, Tsuneyoshi M, Okuda H, Shuin T, Naito S, Kuwano M (2003) Downregulation of Cap43 gene by von Hippel-Lindau tumor suppressor protein in human renal cancer cells. Int J Cancer 105(6):803–810PubMedCrossRef

Nagai MA, Gerhard R, Fregnani JH, Nonogaki S, Rierger RB, Netto MM, Soares FA (2010) Prognostic value of NDRG1 and SPARC protein expression in breast cancer patients. Breast Cancer Res Treat 126(1):1–14PubMedCrossRef

Nishio S, Ushijima K, Tsuda N, Takemoto S, Kawano K, Yamaguchi T, Nishida N, Kakuma T, Tsuda H, Kasamatsu T, Sasajima Y, Kage M, Kuwano M, Kamura T (2008) Cap43/NDRG1/Drg-1 is a molecular target for angiogenesis and a prognostic indicator in cervical adenocarcinoma. Cancer Lett 264(1):36–43PubMedCrossRef

Said HM, Stein S et al (2009) Oxygen-dependent regulation of NDRG1 in human glioblastoma cells in vitro and in vivo. Oncol Rep 21(1):237–246PubMed

Sohda M, Mochida Y, Kato H, Miyazaki T, Nakajima M, Fukuchi M, Manda R, Fukai Y, Masuda N, Ono M, Kuwano M, Kuwano H (2009) Overexpression of Cap43 is associated with malignant status of esophageal cancer. Anticancer Res 29(4):965–970PubMed

Stein S, Thomas EK, Herzog B, Westfall MD, Rocheleau JV, Jackson RS 2nd, Wang M, Liang P (2004) NDRG1 is necessary for p53-dependent apoptosis. J Biol Chem 279(47):48930–48940PubMedCrossRef

Toffoli S, Delaive E, Dieu M, Feron O, Raes M, Michiels C (2009) NDRG1 and CRK-I/II are regulators of endothelial cell migration under Intermittent Hypoxia. Angiogenesis 12(4):339–354PubMedCrossRef

Zhao P, Dai M, Chen W, Li N (2010) Cancer trends in China. Jpn J Clin Oncol 40(4):281–285PubMedCrossRef

Zhou D, Salnikow K, Costa M (1998) Cap43, a novel gene specifically induced by Ni2 + compounds. Cancer Res 58(10):2182–2189PubMed

Titel: NDRG1/Cap43 overexpression in tumor tissues and serum from lung cancer patients
verfasst von: D. Wang
X. Tian
Y. Jiang
Publikationsdatum: 01.11.2012
Verlag: Springer-Verlag
Erschienen in: Journal of Cancer Research and Clinical Oncology / Ausgabe 11/2012
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI: https://doi.org/10.1007/s00432-012-1236-9

Springer Medizin

NDRG1/Cap43 overexpression in tumor tissues and serum from lung cancer patients

Abstract

Purpose

Materials and methods

Results

Conclusions

Neu im Fachgebiet Onkologie

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

Update Onkologie

Springer Medizin

Abstract

Purpose

Materials and methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11/2012

Associations between polymorphisms in IL-12A, IL-12B, IL-12Rβ1, IL-27 gene and serum levels of IL-12p40, IL-27p28 with esophageal cancer

Metronomic chemotherapy in combination with antiangiogenic treatment induces mosaic vascular reduction and tumor growth inhibition in hepatocellular carcinoma xenografts

DNA repair polymorphisms influence the risk of second neoplasm after treatment of childhood acute lymphoblastic leukemia

MGMT testing for glioma in clinical laboratories: discordance with methylation analyses prevents the implementation of routine immunohistochemistry

HIF-1α induced by β-elemene protects human osteosarcoma cells from undergoing apoptosis

Preliminary results of intensity-modulated radiation therapy with helical tomotherapy for prostate cancer

Neu im Fachgebiet Onkologie

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

Update Onkologie